Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

The burden of disease of retinal vein occlusion: review of the literature.

Laouri M, Chen E, Looman M, Gallagher M.

Eye (Lond). 2011 Aug;25(8):981-8. doi: 10.1038/eye.2011.92. Epub 2011 May 6. Review.

2.

Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.

Singer MA, Bell DJ, Woods P, Pollard J, Boord T, Herro A, Porbandarwalla S.

Retina. 2012 Jul;32(7):1289-94. doi: 10.1097/IAE.0b013e318242b838.

PMID:
22466480
3.

Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.

Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P.

Ophthalmology. 2012 Apr;119(4):802-9. doi: 10.1016/j.ophtha.2011.12.005. Epub 2012 Feb 1.

PMID:
22301066
4.

Best practices for treatment of retinal vein occlusion.

Hahn P, Fekrat S.

Curr Opin Ophthalmol. 2012 May;23(3):175-81. doi: 10.1097/ICU.0b013e3283524148. Review.

PMID:
22450223
5.

Resource use and costs of branch and central retinal vein occlusion in the elderly.

Fekrat S, Shea AM, Hammill BG, Nguyen H, Kowalski JW, Schulman KA, Curtis LH.

Curr Med Res Opin. 2010 Jan;26(1):223-30. doi: 10.1185/03007990903439046.

PMID:
19921963
6.

Incremental cost-effectiveness of laser therapy for visual loss secondary to branch retinal vein occlusion.

Brown GC, Brown MM, Sharma S, Busbee B, Brown H.

Ophthalmic Epidemiol. 2002 Feb;9(1):1-10.

PMID:
11815891
7.

Retinal vein occlusions.

Buehl W, Sacu S, Schmidt-Erfurth U.

Dev Ophthalmol. 2010;46:54-72. doi: 10.1159/000320009. Epub 2010 Aug 10.

PMID:
20703032
8.

Branch retinal vein occlusion.

Hamid S, Mirza SA, Shokh I.

J Ayub Med Coll Abbottabad. 2008 Apr-Jun;20(2):128-32. Review.

PMID:
19385476
9.

Interventions for central retinal vein occlusion: an evidence-based systematic review.

Mohamed Q, McIntosh RL, Saw SM, Wong TY.

Ophthalmology. 2007 Mar;114(3):507-19, 524. Review.

PMID:
17324695
10.

Interventions for branch retinal vein occlusion: an evidence-based systematic review.

McIntosh RL, Mohamed Q, Saw SM, Wong TY.

Ophthalmology. 2007 May;114(5):835-54. Epub 2007 Mar 30. Review.

PMID:
17397923
11.

Retinal vein occlusions.

Jonas J, Paques M, Monés J, Glacet-Bernard A.

Dev Ophthalmol. 2010;47:111-35. doi: 10.1159/000320076. Epub 2010 Aug 10. Review.

PMID:
20703046
12.

Retinal vein thrombosis: pathogenesis and management.

Rehak M, Wiedemann P.

J Thromb Haemost. 2010 Sep;8(9):1886-94. doi: 10.1111/j.1538-7836.2010.03909.x. Review.

13.

[Retinal vein occlusions in patients treated with anticoagulant and/or platelet aggregation inhibitors. Five case studies].

Ducos de Lahitte G, Quintyn JC, Leparmentier A, Mathis A.

J Fr Ophtalmol. 2007 Feb;30(2):145-9. French.

14.

[Risk factors and visual prognosis of 407 patients with retinal vein occlusion].

Zhang HR, Xia YJ.

Zhonghua Yan Ke Za Zhi. 1991 Sep;27(5):271-4. Chinese.

PMID:
1815918
15.

Hematologic abnormalities associated with various types of retinal vein occlusion.

Hayreh SS, Zimmerman MB, Podhajsky P.

Graefes Arch Clin Exp Ophthalmol. 2002 Mar;240(3):180-96. Epub 2002 Feb 9.

PMID:
11935275
16.

Nationwide incidence of clinically diagnosed retinal vein occlusion in Korea, 2008 through 2011: preponderance of women and the impact of aging.

Park SJ, Choi NK, Park KH, Woo SJ.

Ophthalmology. 2014 Jun;121(6):1274-80. doi: 10.1016/j.ophtha.2013.12.024. Epub 2014 Feb 1.

PMID:
24491641
17.

Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure.

David R, Zangwill L, Badarna M, Yassur Y.

Ophthalmologica. 1988;197(2):69-74.

PMID:
3186211
18.

[Analysis of 52 cases of retinal vein occlusion treated with laser photocoagulation].

Sun XQ.

Zhonghua Yan Ke Za Zhi. 1991 Sep;27(5):275-8. Chinese.

PMID:
1815919
19.

Exudative retinal detachment subsequent to retinal vein occlusion.

Ravalico G, Battaglia Parodi M.

Ophthalmologica. 1992;205(2):77-82.

PMID:
1475085
20.

Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year.

Kriechbaum K, Prager F, Geitzenauer W, Benesch T, Schütze C, Simader C, Schmidt-Erfurth U.

Ophthalmology. 2009 Dec;116(12):2415-21. doi: 10.1016/j.ophtha.2009.05.001. Epub 2009 Sep 10.

PMID:
19744723

Supplemental Content

Support Center